Shyu et al. [21] suggested that acute stroke patients who complete five days of G-CSF treatment showed greater improvement of neurological scores, including stroke severity and motor scale, and metabolic activity in the area surrounding the infarction core. The gene discussed is CSF3; the disease is stroke disorder.